Table 1.
Baseline characteristics of the enrolled patients.
| PMR (#12) | GCA (#11) | P values | |
|---|---|---|---|
| Mean age in years (SD) | 67.4 (7.5) | 71.1 (6.0) | 0.21 |
| Median disease duration in months (range) | 14 (4–78) | 20 (4–120) | 0.50 |
| Number of patients used methotrexate before (%) | 3 (25.0) | 7 (63.6) | 0.06 |
| Median prednisolone dose in mg (range) | 10.5 (5–17) | 10.4 (7–20) | 0.95 |
| Median CRP in mg/L (interquartile range) | 9.5 (26.2) | 12.0 (24) | 0.70 |
| Mean leflunomide dose in mg (CI 95%) | 14 (10.8–17.4) | 12.7 (9.5–15.8) | 0.49 |
PMR: polymyalgia rheumatica, GCA: giant cell arteritis, SD: standard deviation, CRP: C-reactive protein, CI: confidence interval, #: number of patients enrolled.